Sana (SANA) Surges 14.5% Ahead of Business Announcements
In a statement, Sana Biotechnology, Inc.
Sana Biotechnology Inc. (SANA)
Market is closed
Sector: Healthcare
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Citadel Investment Group Ken Griffin | 6,551,977 | $23,259,519 | +122% | 0% |
| 2. | Baker Bros. Advisors Julian Baker And Felix Baker | 2,030,949 | $7,209,869 | 0.05% | |
| 3. | Integral Health Asset Management Bhagwan Jay Rao | 2,000,000 | $7,100,000 | +34% | 0.48% |
| 4. | Renaissance Technologies Jim Simons | 1,992,500 | $7,073,375 | +879% | 0.01% |
| 5. | Millennium Management Israel Englander | 1,620,000 | $5,751,000 | +104% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 363,637 | $2,000,003.50 | 10,667,387 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing | |
| $5.50 | 727,272 | $3,999,996.00 | 12,446,022 | 2024-02-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.26 | 1,000 | $7,260.00 | 4,541,511 | 2025-01-08 | Filing | |
| $6.71 | 164,912 | $1,106,559.52 | 4,542,511 | 2025-01-08 | Filing | |
| $6.50 | 25,000 | $162,500.00 | 4,707,423 | 2025-01-08 | Filing | |
| $6.11 | 100,000 | $611,000.00 | 4,732,423 | 2025-01-08 | Filing | |
| $3.89 | 150,000 | $583,170.00 | 2,698,121 | 2024-09-25 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 37,431,365 | $132,881,346 | 0.01% | |
| 2. | 25,001,856 | $88,756,589 | 30.33% | |
| 3. | 11,436,503 | $40,599,586 | 0.03% | |
| 4. | 11,226,136 | $39,852,782 | 0% | |
| 5. | 10,175,000 | $36,121,250 | 0.03% |
News See All
Sana Biotechnology (SANA) Wins Analyst Support With Strategic Focus and Cash Strength
Sana Biotechnology Inc. (NASDAQ:SANA) is a must-buy penny stock according to analysts.
11 Must-Buy Penny Stocks to Buy Now
Markets have continued to rally, with the S&P 500 already up by about 15% for the year.
Sana Biotechnology Inc. (SANA) Bolsters Management Team
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the best healthcare penny stocks to buy now. On September 5, the company confirmed the retirement of Executive Vice President Bernard J.
11 Best Healthcare Penny Stocks to Buy Now
The US healthcare sector is one of the biggest in the world, with spending expected to reach $5.3 trillion this year.
Can Sana Biotechnology’s (SANA) Pipeline Momentum Translate into More Share Price Upside?
Sana Biotechnology Inc. (NASDAQ:SANA) is one of the best emerging technology stocks to buy right now.
11 Best Emerging Technology Stocks to Buy Right Now
While the telephone brought comfort, smartphones changed lives. While factories powered economies, artificial intelligence began rewriting them.
Top 10 Stocks Under $10 That Could Triple
The Bureau of Labor Statistics reported that only 22,000 jobs were added in August, much less than the 75,000 jobs that economists polled by Dow Jones had expected.
Citizens JMP Reiterates a Buy Rating on Sana Biotechnology (SANA) With a $5 PT
Sana Biotechnology, Inc. (NASDAQ:SANA) is one of the top strong buy stocks under $5 to buy now.
15 Strong Buy Stocks Under $5 to Buy Now
On August 22, Tom Lee, head of research and chief investment officer of Fundstrat Capital, appeared on CNBC’s ‘Squawk on the Street’ to talk about what he thinks about Fed Chair Powell’s speech...